Navigation Links
Masimo to Present at 23rd Annual Piper Jaffray Health Care Conference
Date:11/15/2011

IRVINE, Calif., Nov. 15, 2011 /PRNewswire/ -- Masimo (NASDAQ: MASI) today announced that its management is scheduled to present at the 23rd Annual Piper Jaffray Health Care Conference at The New York Palace in New York on Tuesday, November 29, 2011 at 9:30 a.m. Eastern Time.  A live audiocast of the presentation will be available on the Masimo website at www.masimo.com.  A replay of the audiocast will be available following the live presentation.

About Masimo Masimo (NASDAQ: MASI) develops innovative monitoring technologies that significantly improve patient care—helping solve "unsolvable" problems.  In 1995, the company debuted Measure-Through Motion and Low Perfusion pulse oximetry, known as Masimo SET®, which virtually eliminated false alarms and increased pulse oximetry's ability to detect life-threatening events.  More than 100 independent and objective studies demonstrate Masimo SET provides the most reliable SpO2 and pulse rate measurements even under the most challenging clinical conditions, including patient motion and low peripheral perfusion.  In 2005, Masimo introduced rainbow® Pulse CO-Oximetry™, allowing noninvasive and continuous monitoring of blood constituents that previously required invasive procedures, including total hemoglobin (SpHb®), oxygen content (SpOC™), carboxyhemoglobin (SpCO®), methemoglobin (SpMet®), and Pleth Variability Index (PVI®), in addition to SpO2, pulse rate, and perfusion index (PI).  In 2009, Masimo introduced rainbow Acoustic Monitoring™, the first-ever noninvasive and continuous monitoring of acoustic respiration rate (RRa™).  Masimo's rainbow SET platform offers a breakthrough in patient safety by helping clinicians detect life-threatening conditions and helping guide treatment options.  Founded in 1989, Masimo has the mission of "Improving Patient Outcome and Reducing Cost of Care …by Taking Noninvasive Monitoring to New Sites and Applications®." Additional information about Masimo and its products may be found at www.masimo.com.Investor Contact:Media Contact:Sheree Aronson

Dana BanksVice President, Investor Relations

Manager, Public RelationsMasimo Corporation

Masimo Corporation(949) 297-7043

(949) 297-7348saronson@masimo.com

dbanks@masimo.comMasimo, SET, Signal Extraction Technology, Improving Patient Outcome and Reducing Cost of Care... by Taking Noninvasive Monitoring to New Sites and Applications, rainbow, SpHb, SpOC, SpCO, SpMet, PVI, rainbow Acoustic Monitoring, RRa, Radical-7, Rad-87, Rad-57,Rad-8, Rad-5,Pulse CO-Oximetry, Pulse CO-Oximeter, Adaptive Threshold Alarm, and SEDLine  are trademarks or registered trademarks of Masimo Corporation. The use of the trademarks Patient SafetyNet and PSN is under license from University HealthSystem Consortium.


'/>"/>

SOURCE Masimo Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Masimo to Present at William Blair & Company 31st Annual Growth Stock Conference
2. New Published Study Demonstrates the Accuracy of Masimo Noninvasive and Continuous Hemoglobin Monitoring in Patients in Surgery and Intensive Care
3. New Clinical Study Finds Masimo Noninvasive Hemoglobin Accurate in Patients with Critically Low Hemoglobin Levels
4. New Johns Hopkins School of Medicine Study Shows Masimo Noninvasive Hemoglobin Monitoring is Accurate During Complex Spine Surgeries
5. Uni.H.A. in France Signs Purchasing Agreement for Masimo SET(R) Pulse Oximetry Products
6. Masimo Radical-7(R) and Rad-57(R) Pulse CO-Oximeters(TM) Awarded Airworthiness Release Certification by the United States Army
7. Childrens Hospital Oakland Standardizes to Masimo Rainbow SET(R) Pulse CO-Oximetry(TM) Technology
8. Masimo to Present at the Thomas Weisel Partners Healthcare Conference 2009
9. New Study Funded By the National Institutes of Health (NIH) Finds Masimo SpCO(R) May Provide a Noninvasive Measure of Acute Asthma Severity in Children
10. Masimo to Present at the Deutsche Bank 34th Annual Health Care Conference
11. Masimo to Report First Quarter 2009 Financial Results on May 5, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/9/2018)... ... August 08, 2018 , ... InTouchMD , the leading provider of data ... be exhibiting at Biotech Week Boston , September 4th – 7th at Hynes ... platform, healthcare’s most powerful all in one marketing solution. Pulse is a multi-use ...
(Date:8/9/2018)... ... August 09, 2018 , ... Rockland Immunochemicals, ... Dr. Birte Aggeler, Director of Antibody Development at Bio-Techne, composed a peer-reviewed article ... published online on August 9, 2018 and will be printed in the September ...
(Date:8/7/2018)... ... August 06, 2018 , ... PetPace , the ... in pet genetic testing, today announced the launch of a groundbreaking study to identify ... of another ongoing general study of pregnant dogs sponsored by PetPace and conducted by ...
(Date:7/31/2018)... (PRWEB) , ... July 31, 2018 , ... ... 2 additional CE/IVD marked molecular quality controls to its expanding CE/IVD product inventory. ... controls to our expanding CE/IVD QC offerings. ZeptoMetrix remains entirely committed to fully ...
Breaking Biology Technology:
(Date:7/26/2018)... ... July 26, 2018 , ... Shirley Holmlund, ... impact of biofield energy healing treated Vitamin D3 on the strength and health ... levels, over 290% improvement in bone mineralization and over 100% increase in ALP, ...
(Date:7/25/2018)... (PRWEB) , ... July 25, 2018 , ... A pioneering ... and Coalition Duchenne dedicated its annual Mt. Kinabalu climb to raising awareness of the ... journey to finding one starts with patients and families willing to participate in a ...
(Date:7/25/2018)... ... July 25, 2018 , ... There are few things worse than ... hygiene can cause for your pet. , Foul mouth odors can indicate tooth decay ... with heart disease also have dental disease severe enough that needs dental care. Pets ...
Breaking Biology News(10 mins):